MedPath

International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

Not Applicable
Active, not recruiting
Conditions
Cervical Cancer
Interventions
Procedure: SLN biopsy + PLN dissection
Procedure: SLN biopsy only
Registration Number
NCT03386734
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

SENTICOL III is large prospective multicenter international randomized study designed to validate the Sentinel Lymph Node (SLN) mapping technique in early cervical cancer. This "validation study" will compare the outcome of patients with negative SLN (experimental arm) vs patients with negative SLN + Pelvic Lymph Node dissection (PLN)(reference arm).

There will be a "quality assurance" program which will be developed in participating centers with detailed requirements in terms of surgeons' qualifications, pathology qualification, SLN ultrastaging, standardization of the procedure, etc. as well as respect of the "safety algorithm".

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
989
Inclusion Criteria

I 1. Patient must be ≥ 18 years old, I 2. With squamous or adenocarcinoma or adenosquamous carcinoma of the cervix (proven by biopsy or cone biopsy), I 3. Stage Ia1 with lymphovascular emboli, Ia2, Ib1 IIa1, Ib2 (clinical stage) of the 2018 FIGO classification (see appendix 1), I 4. Maximum diameter ≤ 40 mm by clinical examination and/or magnetic resonance imaging (MRI), I 5. No suspicious node on pelvic MRI with an exploration up to the left renal vein (according to RECIST 1.1), I 6. ECOG performance status 0-2 (see appendix 2), I 7. Signed informed consent and ability to comply with follow-up, I 8. French subjects: in France, a subject will be eligible for inclusion in this study only if either affiliated to, or a beneficiary of, a social security category.

Exclusion Criteria

E 1. Pregnancy, E 2. Previous pelvic or abdominal cancer, E 3. Previous chemotherapy and/or radiation therapy for the cervical cancer (previous brachytherapy is accepted), E 4. Proven allergy to blue dye, isotope or indocyanine green (ICG) E 5. Other malignancy within the last 5 years except for treated cancer free of disease and treatment, E 6. Patients with synchronous cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SLN biopsy + PLN dissectionSLN biopsy + PLN dissectionSLN biopsy + full pelvic lymph node dissection (PLN) will be performed. The radical hysterectomy or trachelectomy will be done.
SLN biopsy onlySLN biopsy onlySentinel lymph node (SLN) biopsy only. A full lymphadenectomy will not be performed. The radical hysterectomy or trachelectomy will be done.
Primary Outcome Measures
NameTimeMethod
Disease Free Survival (DFS)Year 3

Composite outcome: the time interval between randomization and recurrence (local/distant) or second cancer or death (all causes), whichever occurs first.

This time interval will be analysed concomitantly with HR-QoL scores as a composite outcome.

Health-related quality of life (HR-QoL)Year 3

Composite outcome: significant deterioration will specifically be assessed through 3 targeted dimensions (pain score, global health score and physical functioning scores) in EORTC QLQ-C30 and QLQ-CX24 questionnaires.

These scores will be analysed concomitantly with DFS as a composite outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (106)

CHC MontLégia

🇧🇪

Liège, Belgium

CHU d'Amiens

🇫🇷

Amiens, France

Hospital Universitario La Paz

🇪🇸

Madrid, Spain

CHU de la Réunion

🇫🇷

Saint-Denis, La Réunion, France

CHUV

🇨🇭

Lausanne, Switzerland

Hospital Ramón y Cajal

🇪🇸

Madrid, Spain

Hospital Erasto Gaertner

🇧🇷

Curitiba, Parana, Brazil

Barretos Cancer Hospital

🇧🇷

Campo Grande, Brazil

Brazilian National Cancer Institute

🇧🇷

Rio De Janeiro, Brazil

AC Camargo Cancer Center - Sao Paulo

🇧🇷

São Paulo, Brazil

Hospital Amaral Carvalho de Jaù

🇧🇷

São Paulo, Brazil

Hospital Israelita Albert Einstein

🇧🇷

São Paulo, Brazil

CIUSSS de l'Est-de-I'lle-de-Montreal Hopital Maisonneuve-Rosemont (CAHA)

🇨🇦

Montréal, Canada

CHUM Centre Hospitalier de l'Université de Montréal

🇨🇦

Montréal, Canada

CHU Québec (Hôtel Dieu)

🇨🇦

Québec, Canada

Allan Blair Cancer Centre (CASA)

🇨🇦

Regina, Canada

Clinical Research Unit at Vancouver Coastal Health Authority (CAVG)

🇨🇦

Vancouver, Canada

Saskatoon Cancer Centre.(CASS)

🇨🇦

Saskatoon, Canada

CIUSS de l'Estrie - Centre hospitalier universitaire de Sherbrooke - CAGH

🇨🇦

Sherbrooke, Canada

Cancer Hospital of University of Chinese Academy of Science

🇨🇳

Hangzhou, Zhejiang, China

CancerCare Manitoba

🇨🇦

Winnipeg, Canada

The 1st Affiliated Hospital

🇨🇳

Wenzhou, China

University Hospital Olomouc

🇨🇿

Olomouc, Czechia

University Hospital Ostrava

🇨🇿

Ostrava-Poruba, Czechia

General University Hospital

🇨🇿

Praha, Czechia

University Hospital Bulovka

🇨🇿

Praha, Czechia

Grand Hôpital de l'Est Francilien

🇫🇷

Paris, Marne-le-Vallée, France

CHU de Besançon

🇫🇷

Besançon, France

Institut Bergonié

🇫🇷

Bordeaux, France

Clinique Tivoli-Ducos

🇫🇷

Bordeaux, France

Center de Lutte Contre le Cancer François Baclesse

🇫🇷

Caen, France

CHU de Caen

🇫🇷

Caen, France

CHU de Clermont-Ferrand - Hôpital d'Estaing

🇫🇷

Clermont-Ferrand, France

CHU de Dijon Bourgogne

🇫🇷

Dijon, France

Centre de Lutte Contre le Cancer Jean Perrin

🇫🇷

Clermont-Ferrand, France

Hôpital Antoine Béclère

🇫🇷

Clamart, France

CHI de Créteil

🇫🇷

Créteil, France

Hôpital Bicêtre

🇫🇷

Le Kremlin-Bicêtre, France

Centre Jean Godinot

🇫🇷

Reims, France

Hôpital Européen Georges Pompidou

🇫🇷

Paris, France

Centre Georges François Leclerc

🇫🇷

Dijon, France

Centre Oscar Lambret

🇫🇷

Lille, France

CHRU de Lille - Hôpital Jeanne de Flandre

🇫🇷

Lille, France

Hôpitaux Universitaires de Strasbourg

🇫🇷

Strasbourg, France

CHU de Limoges

🇫🇷

Limoges, France

Hôpital de la Conception

🇫🇷

Marseille, France

Groupement Hospitalier Est - Hôpital Femme Mère Enfant

🇫🇷

Lyon, France

Institut de Cancérologie de Montpellier Val d'Aurelle

🇫🇷

Montpellier, France

Hôpital Saint-Joseph

🇫🇷

Marseille, France

Institut Paoli Calmettes

🇫🇷

Marseille, France

CH de Mulhouse - Hôpital du Hasenrain

🇫🇷

Mulhouse, France

Institut de Cancérologie de l'Ouest - Centre René Gauducheau

🇫🇷

Nantes, France

Institut Curie - site de Paris

🇫🇷

Paris, France

Centre de Lutte Contre le Cancer Antoine Lacassagne

🇫🇷

Nice, France

Groupe Hospitalier Diaconesses Croix Saint Simon

🇫🇷

Paris, France

Centre Hospitalier Bichat - Claude Bernard

🇫🇷

Paris, France

Groupe Hospitalier la Pitié Salpêtrière

🇫🇷

Paris, France

Hôpital de Poissy-Saint-Germain-en-Laye

🇫🇷

Poissy, France

Hôpital Lariboisière

🇫🇷

Paris, France

Hôpital Tenon

🇫🇷

Paris, France

CH Lyon Sud

🇫🇷

Pierre-Bénite, France

CHU de Poitiers - Hôpital de la Milétrie

🇫🇷

Poitiers, France

Clinique Mathilde

🇫🇷

Rouen, France

Centre Henri Becquerel

🇫🇷

Rouen, France

CHU de Reims - Hôpital Robert Debré

🇫🇷

Reims, France

CHU de Rennes - Hôpital Sud

🇫🇷

Rennes, France

Institut de Cancérologie de Lorraine

🇫🇷

Vandoeuvre les nancy, France

Centre de Lutte Contre le Cancer Gustave Roussy

🇫🇷

Villejuif, France

Institut Universitaire du Cancer de Toulouse

🇫🇷

Toulouse, France

Universitätsklinikum Düsseldorf

🇩🇪

Düsseldorf, Germany

Vivantes Humboldt-Klinikum

🇩🇪

Berlin, Germany

Universitätsklinikum Carl Gustav Carus

🇩🇪

Dresden, Germany

Frauenklinik Fürth

🇩🇪

Fürth, Germany

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

Kliniken Essen Mitte, Evang. Huyssens-Stiftung

🇩🇪

Essen, Germany

Florence-Nightingale-Krankenhaus

🇩🇪

Düsseldorf, Germany

Universitätsklinikum Gießen und Marburg - UKGM Giessen

🇩🇪

Gießen, Germany

Städtisches Klinikum Karlsruhe

🇩🇪

Karlsruhe, Germany

Universitätsklinikum Jena

🇩🇪

Jena, Germany

Universitätsklinikum Ulm

🇩🇪

Ulm, Germany

Medizinische Hochschule Hannover

🇩🇪

Hanover, Germany

Universitätsklinikum Schleswig-Holstein, Campus Lübeck

🇩🇪

Lübeck, Germany

Klinikum Kassel

🇩🇪

Kassel, Germany

Universitätsklinikum Münster

🇩🇪

Münster, Germany

Klinikum der Universität München

🇩🇪

München, Germany

UFK am Klinikum Südstradt Rostock

🇩🇪

Rostock, Germany

Universitaätsklinikum Tübingen

🇩🇪

Tübingen, Germany

Klinikum Wolfsburg

🇩🇪

Wolfsburg, Germany

Basavatarakam Indo-American Cancer Hospital & Research Institute

🇮🇳

Hyderabad, Telangana, India

Istituto Europe di Oncologia

🇮🇹

Milano, Italy

Chittaranjan National Cancer Institute (CNCI)

🇮🇳

Kolkata, West Bengal, India

University Hospital Bratislava

🇸🇰

Bratislava, Slovakia

Ospedale San Gerardo Monza

🇮🇹

Monza, Italy

Saitama Medical University International Medical Center

🇯🇵

Saitama, Japan

Oslo Universitetssykehus HF Radiumhospitalet

🇳🇴

Oslo, Norway

National Oncology Institute

🇸🇰

Bratislava, Slovakia

Hospital Clinic de Barcelona

🇪🇸

Barcelona, Spain

University Hospital Trencin

🇸🇰

Trenčín, Slovakia

Hospital Universitario Vall D´Hebron

🇪🇸

Barcelona, Spain

Hopital Clinico Universitario de Valencia

🇪🇸

Girona, Spain

Hospital General Universitario de Castellón

🇪🇸

Castelló de la Plana, Spain

Hospital Universitario de Girona Dr. Josep Trueta

🇪🇸

Girona, Spain

Hospital Universitario de Donostia

🇪🇸

Donostia, Spain

Hospital Alvaro Cunqueiro

🇪🇸

Vigo, Spain

Hospital Clínico Universitario San Carlos

🇪🇸

Madrid, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath